Sinaptica’s neuromodulation device aces Phase II Alzheimer’s trial
Alzheimer’s patients using the SinaptiStim system experienced a 44% reduction in disease progression over 12 months.
Medical Devices
Nexalin trials Halo neurostimulation device in traumatic brain injury
Mixed results for Nexalin’s transcranial alternating current stimulation trial
Adaptive deep brain stimulation trial results poised to “transform” Parkinson’s disease
SetPoint’s neuromodulation implant wins IDE for multiple sclerosis study
Synchron’s BCI meets primary endpoint in feasibility trial
Wesper sleep platform reduces nerve stimulation titration time by 45%
Bridge to Life bolsters efficacy data for HOPE perfusion device in liver transplant
